Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. (*ST Suwu) experienced a significant stock price drop exceeding 12% from August 13 to 15, 2025, indicating abnormal volatility [1] Company Situation - The company conducted a self-examination and found no significant changes in daily operations or major events [1] - The company is facing multiple risks, including the potential for forced delisting due to major legal violations [1] - The balance of non-operating funds occupied by related parties of the controlling shareholder amounts to 1,692.6071 million yuan [1] - The company's stock price has been below 1 yuan for two consecutive days, and if it remains below this threshold for 20 consecutive days, it may face termination of listing [1] - Additional challenges include contract terminations in business cooperation and the freezing of shares held by the controlling shareholder [1] - The company has issued a reminder to investors to be aware of risks and to invest rationally [1]
*ST苏吴：公司日常生产经营、重大事项等方面未现重大变化
Xin Lang Cai Jing·2025-08-15 08:52